Day Range3.810 - 4.204 | 52 Wk Range1.592 - 23.000 | Open / Close4.000 / - | Float / Outstanding666.820K / 678.219K |
Vol / Avg.7.522K / 83.737K | Mkt Cap2.777M | P/E- | 50d Avg. Price3.250 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float666.820K | EPS-16.600 |
SenesTech Stock (NASDAQ: SNES) stock price, news, charts, stock research, profile.
Day Range3.810 - 4.204 | 52 Wk Range1.592 - 23.000 | Open / Close4.000 / - | Float / Outstanding666.820K / 678.219K |
Vol / Avg.7.522K / 83.737K | Mkt Cap2.777M | P/E- | 50d Avg. Price3.250 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float666.820K | EPS-16.600 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -4.200 | -4.400 | -0.2000 | ||||
REV | 420.000K | 250.000K | -170.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SenesTech (NASDAQ: SNES) through any online brokerage.
Other companies in SenesTech’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Sonoma Pharmaceuticals (NASDAQ:SNOA), Palisade Bio (NASDAQ:PALI) and BiondVax Pharmaceuticals (NASDAQ:BVXV).
The latest price target for SenesTech (NASDAQ: SNES) was reported by HC Wainwright & Co. on Wednesday, January 20, 2021. The analyst firm set a price target for 4.00 expecting SNES to fall to within 12 months (a possible -2.32% downside). 0 analyst firms have reported ratings in the last year.
The stock price for SenesTech (NASDAQ: SNES) is $4.095 last updated Today at January 31, 2023 at 5:28 PM UTC.
There are no upcoming dividends for SenesTech.
SenesTech’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SenesTech.
SenesTech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SenesTech Stock (NASDAQ: SNES) stock price, news, charts, stock research, profile.
Day Range3.810 - 4.204 | 52 Wk Range1.592 - 23.000 | Open / Close4.000 / - | Float / Outstanding666.820K / 678.219K |
Vol / Avg.7.522K / 83.737K | Mkt Cap2.777M | P/E- | 50d Avg. Price3.250 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float666.820K | EPS-16.600 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -4.200 | -4.400 | -0.2000 | ||||
REV | 420.000K | 250.000K | -170.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SenesTech (NASDAQ: SNES) through any online brokerage.
Other companies in SenesTech’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Sonoma Pharmaceuticals (NASDAQ:SNOA), Palisade Bio (NASDAQ:PALI) and BiondVax Pharmaceuticals (NASDAQ:BVXV).
The latest price target for SenesTech (NASDAQ: SNES) was reported by HC Wainwright & Co. on Wednesday, January 20, 2021. The analyst firm set a price target for 4.00 expecting SNES to fall to within 12 months (a possible -2.32% downside). 0 analyst firms have reported ratings in the last year.
The stock price for SenesTech (NASDAQ: SNES) is $4.095 last updated Today at January 31, 2023 at 5:28 PM UTC.
There are no upcoming dividends for SenesTech.
SenesTech’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SenesTech.
SenesTech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SenesTech Stock (NASDAQ: SNES) stock price, news, charts, stock research, profile.
Day Range3.810 - 4.204 | 52 Wk Range1.592 - 23.000 | Open / Close4.000 / - | Float / Outstanding666.820K / 678.219K |
Vol / Avg.7.522K / 83.737K | Mkt Cap2.777M | P/E- | 50d Avg. Price3.250 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float666.820K | EPS-16.600 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -4.200 | -4.400 | -0.2000 | ||||
REV | 420.000K | 250.000K | -170.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SenesTech (NASDAQ: SNES) through any online brokerage.
Other companies in SenesTech’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Sonoma Pharmaceuticals (NASDAQ:SNOA), Palisade Bio (NASDAQ:PALI) and BiondVax Pharmaceuticals (NASDAQ:BVXV).
The latest price target for SenesTech (NASDAQ: SNES) was reported by HC Wainwright & Co. on Wednesday, January 20, 2021. The analyst firm set a price target for 4.00 expecting SNES to fall to within 12 months (a possible -2.32% downside). 0 analyst firms have reported ratings in the last year.
The stock price for SenesTech (NASDAQ: SNES) is $4.095 last updated Today at January 31, 2023 at 5:28 PM UTC.
There are no upcoming dividends for SenesTech.
SenesTech’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SenesTech.
SenesTech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SenesTech Stock (NASDAQ: SNES) stock price, news, charts, stock research, profile.
Day Range3.810 - 4.204 | 52 Wk Range1.592 - 23.000 | Open / Close4.000 / - | Float / Outstanding666.820K / 678.219K |
Vol / Avg.7.522K / 83.737K | Mkt Cap2.777M | P/E- | 50d Avg. Price3.250 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float666.820K | EPS-16.600 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -4.200 | -4.400 | -0.2000 | ||||
REV | 420.000K | 250.000K | -170.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SenesTech (NASDAQ: SNES) through any online brokerage.
Other companies in SenesTech’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Sonoma Pharmaceuticals (NASDAQ:SNOA), Palisade Bio (NASDAQ:PALI) and BiondVax Pharmaceuticals (NASDAQ:BVXV).
The latest price target for SenesTech (NASDAQ: SNES) was reported by HC Wainwright & Co. on Wednesday, January 20, 2021. The analyst firm set a price target for 4.00 expecting SNES to fall to within 12 months (a possible -2.32% downside). 0 analyst firms have reported ratings in the last year.
The stock price for SenesTech (NASDAQ: SNES) is $4.095 last updated Today at January 31, 2023 at 5:28 PM UTC.
There are no upcoming dividends for SenesTech.
SenesTech’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SenesTech.
SenesTech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SenesTech Stock (NASDAQ: SNES) stock price, news, charts, stock research, profile.
Day Range3.810 - 4.204 | 52 Wk Range1.592 - 23.000 | Open / Close4.000 / - | Float / Outstanding666.820K / 678.219K |
Vol / Avg.7.522K / 83.737K | Mkt Cap2.777M | P/E- | 50d Avg. Price3.250 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float666.820K | EPS-16.600 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -4.200 | -4.400 | -0.2000 | ||||
REV | 420.000K | 250.000K | -170.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SenesTech (NASDAQ: SNES) through any online brokerage.
Other companies in SenesTech’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Sonoma Pharmaceuticals (NASDAQ:SNOA), Palisade Bio (NASDAQ:PALI) and BiondVax Pharmaceuticals (NASDAQ:BVXV).
The latest price target for SenesTech (NASDAQ: SNES) was reported by HC Wainwright & Co. on Wednesday, January 20, 2021. The analyst firm set a price target for 4.00 expecting SNES to fall to within 12 months (a possible -2.32% downside). 0 analyst firms have reported ratings in the last year.
The stock price for SenesTech (NASDAQ: SNES) is $4.095 last updated Today at January 31, 2023 at 5:28 PM UTC.
There are no upcoming dividends for SenesTech.
SenesTech’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SenesTech.
SenesTech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SenesTech Stock (NASDAQ: SNES) stock price, news, charts, stock research, profile.
Day Range3.810 - 4.204 | 52 Wk Range1.592 - 23.000 | Open / Close4.000 / - | Float / Outstanding666.820K / 678.219K |
Vol / Avg.7.522K / 83.737K | Mkt Cap2.777M | P/E- | 50d Avg. Price3.250 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float666.820K | EPS-16.600 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -4.200 | -4.400 | -0.2000 | ||||
REV | 420.000K | 250.000K | -170.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SenesTech (NASDAQ: SNES) through any online brokerage.
Other companies in SenesTech’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Sonoma Pharmaceuticals (NASDAQ:SNOA), Palisade Bio (NASDAQ:PALI) and BiondVax Pharmaceuticals (NASDAQ:BVXV).
The latest price target for SenesTech (NASDAQ: SNES) was reported by HC Wainwright & Co. on Wednesday, January 20, 2021. The analyst firm set a price target for 4.00 expecting SNES to fall to within 12 months (a possible -2.32% downside). 0 analyst firms have reported ratings in the last year.
The stock price for SenesTech (NASDAQ: SNES) is $4.095 last updated Today at January 31, 2023 at 5:28 PM UTC.
There are no upcoming dividends for SenesTech.
SenesTech’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SenesTech.
SenesTech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SenesTech Stock (NASDAQ: SNES) stock price, news, charts, stock research, profile.
Day Range3.810 - 4.204 | 52 Wk Range1.592 - 23.000 | Open / Close4.000 / - | Float / Outstanding666.820K / 678.219K |
Vol / Avg.7.522K / 83.737K | Mkt Cap2.777M | P/E- | 50d Avg. Price3.250 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float666.820K | EPS-16.600 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -4.200 | -4.400 | -0.2000 | ||||
REV | 420.000K | 250.000K | -170.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SenesTech (NASDAQ: SNES) through any online brokerage.
Other companies in SenesTech’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Sonoma Pharmaceuticals (NASDAQ:SNOA), Palisade Bio (NASDAQ:PALI) and BiondVax Pharmaceuticals (NASDAQ:BVXV).
The latest price target for SenesTech (NASDAQ: SNES) was reported by HC Wainwright & Co. on Wednesday, January 20, 2021. The analyst firm set a price target for 4.00 expecting SNES to fall to within 12 months (a possible -2.32% downside). 0 analyst firms have reported ratings in the last year.
The stock price for SenesTech (NASDAQ: SNES) is $4.095 last updated Today at January 31, 2023 at 5:28 PM UTC.
There are no upcoming dividends for SenesTech.
SenesTech’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SenesTech.
SenesTech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SenesTech Stock (NASDAQ: SNES) stock price, news, charts, stock research, profile.
Day Range3.810 - 4.204 | 52 Wk Range1.592 - 23.000 | Open / Close4.000 / - | Float / Outstanding666.820K / 678.219K |
Vol / Avg.7.522K / 83.737K | Mkt Cap2.777M | P/E- | 50d Avg. Price3.250 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float666.820K | EPS-16.600 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -4.200 | -4.400 | -0.2000 | ||||
REV | 420.000K | 250.000K | -170.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SenesTech (NASDAQ: SNES) through any online brokerage.
Other companies in SenesTech’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Sonoma Pharmaceuticals (NASDAQ:SNOA), Palisade Bio (NASDAQ:PALI) and BiondVax Pharmaceuticals (NASDAQ:BVXV).
The latest price target for SenesTech (NASDAQ: SNES) was reported by HC Wainwright & Co. on Wednesday, January 20, 2021. The analyst firm set a price target for 4.00 expecting SNES to fall to within 12 months (a possible -2.32% downside). 0 analyst firms have reported ratings in the last year.
The stock price for SenesTech (NASDAQ: SNES) is $4.095 last updated Today at January 31, 2023 at 5:28 PM UTC.
There are no upcoming dividends for SenesTech.
SenesTech’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SenesTech.
SenesTech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SenesTech Stock (NASDAQ: SNES) stock price, news, charts, stock research, profile.
Day Range3.810 - 4.204 | 52 Wk Range1.592 - 23.000 | Open / Close4.000 / - | Float / Outstanding666.820K / 678.219K |
Vol / Avg.7.522K / 83.737K | Mkt Cap2.777M | P/E- | 50d Avg. Price3.250 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float666.820K | EPS-16.600 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -4.200 | -4.400 | -0.2000 | ||||
REV | 420.000K | 250.000K | -170.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SenesTech (NASDAQ: SNES) through any online brokerage.
Other companies in SenesTech’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Sonoma Pharmaceuticals (NASDAQ:SNOA), Palisade Bio (NASDAQ:PALI) and BiondVax Pharmaceuticals (NASDAQ:BVXV).
The latest price target for SenesTech (NASDAQ: SNES) was reported by HC Wainwright & Co. on Wednesday, January 20, 2021. The analyst firm set a price target for 4.00 expecting SNES to fall to within 12 months (a possible -2.32% downside). 0 analyst firms have reported ratings in the last year.
The stock price for SenesTech (NASDAQ: SNES) is $4.095 last updated Today at January 31, 2023 at 5:28 PM UTC.
There are no upcoming dividends for SenesTech.
SenesTech’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SenesTech.
SenesTech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.